Applied Genetic Technologies reported $93.39M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alimera Sciences ALIM:US $ 43.63M 1.6M
Applied Genetic Technologies AGTC:US $ 93.39M 16.32M
Avrobio Inc AVRO:US 211.66M 21.86M
Biogen BIIB:US $ 7162.3M 21.4M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Celldex Therapeutics CLDX:US $ 426.56M 258.95M
Cti Biopharma CTIC:US $ 99.04M 24.23M
Gilead Sciences GILD:US $ 14200M 275M
Insmed INSM:US $ 958.98M 79.21M
Life Technologies LIFE:US $ 121.57M 75.17M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Rigel Pharmaceuticals RIGL:US $ 171.1M 13.09M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M